Press & Statements

CSRxP Appreciates HELP Leaders’ Bipartisan Commitment to Lowering Drug Prices

May 23, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released Read More

Lawmakers Keeping Up Bipartisan Momentum On Drug Pricing

May 21, 2019

House Energy & Commerce Subcommittee Takes Up Transparency Bills Tuesday Read More

CSRxP: House Passage of Bipartisan CREATES Act a Pivotal Moment for Patients

May 16, 2019

Applauds Lawmakers for Advancing Market-Based Solutions to Lower Drug Prices Read More

CSRxP Encourages U.S. House of Representatives to Pass Bipartisan CREATES Act

May 16, 2019

Commends Lawmakers of Both Parties for Working Together to Advance Key Drug Read More

CSRxP Applauds Bipartisan Bill To Strengthen Drug Pricing Transparency

May 14, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today Read More

CSRxP Study Confirms: Big Pharma Invests Boldly in Profits and Advertising — Not R&D

May 14, 2019

Analysis Finds Industry Spending on Advertising, Overhead and Profits More Read More

CSRxP Praises FDA For Finalizing Guidance On Interchangeable Biologics

May 10, 2019

Clearer Guidelines Will Increase Choice and Help Lower Prices Washington Read More

CSRxP: Congress Takes First Step On Drug Pricing, Now Lawmakers Must Deliver

May 8, 2019

Encourages House Leaders To Keep The Momentum Going Following Passage Of First Read More

CSRxP Urges House Lawmakers to Pass First Drug Pricing Bills of the Year

May 8, 2019

Vote On Orange And Purple Book Bills Should Mark Beginning Of A Series Of Read More

CSRxP Praises Administration For Implementing Direct-To-Consumer Advertising Rule

May 8, 2019

Greater List Price Transparency Will Help Hold Big Pharma Accountable  Read More

CSRxP: Senate Judiciary Lawmakers Grill Big Pharma, Demonstrate Bipartisan Commitment To Action

May 7, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today Read More

CSRxP Welcomes Senate Scrutiny Of Big Pharma’s Patent Abuse

May 6, 2019

Encourages Judiciary Committee To Hold Drug Makers Accountable Read More